Axsome Therapeutics, Inc. short interest in 2023
In 2023, Axsome Therapeutics, Inc.'s disclosed short interest ran from 18.27% of shares outstanding on 13 Jan 2023 to 17.80% on 29 Dec 2023, a change of -0.47 percentage points. The year's high was 21.35% on 14 Jul 2023 and its low 15.52% on 31 Oct 2023, averaging 18.05% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.45 days on 31 Aug 2023. Full history: Axsome Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 18.27% (13 Jan 2023)
- End of year
- 17.80% (29 Dec 2023)
- Change
- -0.47 pp
- High
- 21.35% (14 Jul 2023)
- Low
- 15.52% (31 Oct 2023)
- Average
- 18.05%
- Highest days to cover
- 14.45 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 18.27% | 6.71 | |
| 31 Jan 2023 | 17.58% | 9.45 | |
| 15 Feb 2023 | 18.55% | 7.81 | |
| 28 Feb 2023 | 19.34% | 8.20 | results (8-K), 10-K filed |
| 15 Mar 2023 | 19.65% | 8.64 | |
| 31 Mar 2023 | 18.90% | 11.05 | |
| 14 Apr 2023 | 18.06% | 9.29 | |
| 28 Apr 2023 | 18.40% | 11.13 | |
| 15 May 2023 | 17.60% | 8.64 | results (8-K), 10-Q filed |
| 31 May 2023 | 17.77% | 11.70 | |
| 15 Jun 2023 | 17.81% | 9.79 | |
| 30 Jun 2023 | 20.97% | 6.33 | |
| 14 Jul 2023 | 21.35% | 10.67 | |
| 31 Jul 2023 | 19.19% | 11.68 | |
| 15 Aug 2023 | 18.09% | 9.23 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 17.46% | 14.45 | |
| 15 Sep 2023 | 17.21% | 11.78 | |
| 29 Sep 2023 | 15.82% | 11.80 | |
| 13 Oct 2023 | 16.08% | 11.56 | |
| 31 Oct 2023 | 15.52% | 12.15 | |
| 15 Nov 2023 | 16.15% | 9.26 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 17.86% | 13.69 | |
| 15 Dec 2023 | 17.66% | 12.97 | |
| 29 Dec 2023 | 17.80% | 13.54 |
See also: Axsome Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.